1.Pearls and Potential Pitfalls for Correct Diagnosis of Ovarian Cystadenofibroma in MRI:A Pictorial Essay
Giacomo AVESANI ; Gianluca CALIOLO ; Benedetta GUI ; Federica PETTA ; Camilla PANICO ; Viviana La MANNA ; Francesca MORO ; Antonia Carla TESTA ; Giovanni SCAMBIA ; Riccardo MANFREDI
Korean Journal of Radiology 2021;22(11):1809-1821
Ovarian cystadenofibroma is a benign ovarian tumor that is characterized by a consistent percentage of masses, which remain indeterminate in ultrasonography and require magnetic resonance (MR) investigation; they may mimic borderline or malignant lesions. Three main morphologic patterns, resembling different ovarian neoplasms, can be identified in cystadenofibromas:multilocular solid lesions, unilocular cystic lesions with parietal thickening, and purely cystic masses. However, a cystoadenofibroma has typical features, such as T2-weighted hypointensity associated with no restrictions in diffusion-weighted imaging (the so-called “dark-dark appearance”) and progressive post-contrast enhancement (type I perfusion curve). The purpose of this study was to review the features of ovarian cystadenofibromas in MR imaging and to suggest pearls and pitfalls regarding their correct diagnosis.
2.Immunotherapy-Related Imaging Findings in Patients with Gynecological Malignancies: What Radiologists Need to Know
Luca RUSSO ; Giacomo AVESANI ; Benedetta GUI ; Charlotte Marguerite Lucille TROMBADORI ; Vanda SALUTARI ; Maria Teresa PERRI ; Valerio Di PAOLA ; Elena RODOLFINO ; Giovanni SCAMBIA ; Riccardo MANFREDI
Korean Journal of Radiology 2021;22(8):1310-1322
Immunotherapy is an effective treatment option for gynecological malignancies. Radiologists dealing with gynecological patients undergoing treatment with immune checkpoint inhibitors should be aware of unconventional immune-related imaging features for the evaluation of tumor response and immune-related adverse events. In this paper, immune checkpoint inhibitors used for gynecological malignancies and their mechanisms of action are briefly presented. In the second part, patterns of pseudoprogression are illustrated, and different forms of immune-related adverse events are discussed.
3.Immunotherapy-Related Imaging Findings in Patients with Gynecological Malignancies: What Radiologists Need to Know
Luca RUSSO ; Giacomo AVESANI ; Benedetta GUI ; Charlotte Marguerite Lucille TROMBADORI ; Vanda SALUTARI ; Maria Teresa PERRI ; Valerio Di PAOLA ; Elena RODOLFINO ; Giovanni SCAMBIA ; Riccardo MANFREDI
Korean Journal of Radiology 2021;22(8):1310-1322
Immunotherapy is an effective treatment option for gynecological malignancies. Radiologists dealing with gynecological patients undergoing treatment with immune checkpoint inhibitors should be aware of unconventional immune-related imaging features for the evaluation of tumor response and immune-related adverse events. In this paper, immune checkpoint inhibitors used for gynecological malignancies and their mechanisms of action are briefly presented. In the second part, patterns of pseudoprogression are illustrated, and different forms of immune-related adverse events are discussed.